• Home
  • Search Results
  • Effects of associated SCF and G-CSF on liver injury two weeks after liver damage: A model induced by thioacetamide administration.

Effects of associated SCF and G-CSF on liver injury two weeks after liver damage: A model induced by thioacetamide administration.

Molecular biology research communications (2014-06-01)
Mohsen Esmaili, Durdi Qujeq, Ali Asghar Yoonesi, Farideh Feizi, Mohammad Ranaee
ABSTRACT

The present study aimed at investigating the beneficial effects of co-administering granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a model of chronic liver injury induced by thioacetamide (TAA). Biochemical and histopathology- cal examinations were performed on serum and liver specimens. At the end of the treatment period, the rats were anesthetized with ether, serum was collected and sections of randomly selected fixed liver specimens from each group were embedded in paraffin and processed for light microscopy by staining individual sections with hematoxylin- eosin (HE) stain. Administration of a combination of G-CSF+SCF was carried out two weeks after the TAA treatment. Livers of rats treated with TAA alone exhibited damage, which was significantly less in the group treated with the combination of SCF and G-CSF. Albumin level was 2.35 (g/dl) in the G-CSF+SCF and 1.03 in the TAA- alone group. These differences were statistically significant (P<0.05). Also, in the G- CSF+SCF and TAA group the total protein means (7.16 versus 3.57 mg/dl, respective- ly) were higher than those of the TAA-alone group, and the differences were statistically significant (P<0.05). In the G-CSF+SCF and TAA group the total bilirubin content mean (0.15 versus 0.14 mg/dl, respectively) this difference was not statistically significant (P>0.05).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Granulocyte colony-stimulating factor human, G-CSF, recombinant, expressed in E. coli, suitable for cell culture

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.